Damage to the insula leads to decreased nicotine withdrawal during abstinence

Addiction

Volumn 110, Issue 12, 2015, Pages 1994-2003

  Abdolahi, Amir ^a,b   Williams, Geoffrey C ^c   Benesch, Curtis G ^c   Wang, Henry Z ^c   Spitzer, Eric M ^d   Scott, Bryan E ^d   Block, Robert C ^a   van Wijngaarden, Edwin ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b PHILIPS RESEARCH LABORATORIES   (Netherlands)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d Rochester General Health System   (United States)

Author keywords

Abstinence; Insular cortex; Nicotine; Smoking; Stroke; Withdrawal

Indexed keywords

NICOTINE; NICOTINE GUM; NICOTINIC AGENT;

BRAIN CORTEX; BRAIN DISEASE; BRAIN ISCHEMIA; CLINICAL TRIAL; COMPLICATION; FEMALE; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; MALE; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOKING CESSATION; STROKE; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

BRAIN DISEASES; BRAIN ISCHEMIA; CEREBRAL CORTEX; FEMALE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; NICOTINE; NICOTINIC AGONISTS; SMOKING CESSATION; STROKE; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84947040210     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13061     Document Type: Article

References (51)

1. US Department of Health and Social Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014.
2. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
3. Centers for Disease Control and Prevention. Smoking and Tobacco Use, Health Effects of Cigarette Smoking, updated 21March 2011. Available at: http://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/ (accessed 25 August 2014).
4. Rigotti N. A. Treatment of tobacco use and dependence. N Engl J Med 2002; 346: 506-12.
5. Fiore M. C., Jaen C. R., Baker T. B., Bailey W. C., Benowitz N. L., Curry S. J. et al. Treating Tobacco Use and Dependence: 2008 Update. U.S. Public Health Service Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008.
6. Islam N., Rahman S. Improved treatment of nicotine addiction and emerging pulmonary drug delivery. Drug Discov Ther 2012; 6: 123-32.
7. Caponnetto P., Russo C., Polosa R. Smoking cessation: present status and future perspectives. Curr Opin Pharmacol 2012; 12: 229-37.
8. Naqvi N. H., Bechara A. The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making. Brain Struct Funct 2010; 214: 435-50.
9. Naqvi N. H., Rudrauf D., Damasio H., Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science 2007; 315: 531-4.
10. Abdolahi A., Acosta G., Breslin F. J., Hemby S. E., Lynch W. J. Incubation of nicotine seeking is associated with enhanced protein kinase A-regulated signaling of dopamine- and cAMP-regulated phosphoprotein of 32 kDa in the insular cortex. Eur J Neurosci 2010; 31: 733-41.
11. Contreras M., Ceric F., Torrealba F. Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium. Science 2007; 318: 655-8.
12. Hollander J. A., Lu Q., Cameron M. D., Kamenecka T. M., Kenny P. J. Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci USA 2008; 105: 19480-5.
13. Forget B., Pushparaj A., Le Foll B. Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction. Biol Psychiatry 2010; 68: 265-71.
14. McBride D., Barrett S. P., Kelly J. T., Aw A., Dagher A. Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study. Neuropsychopharmacology 2006; 31: 2728-38.
15. Franklin T. R., Wang Z., Wang J., Sciortino N., Harper D., Li Y. et al. Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology 2007; 32: 2301-9.
16. Brody A. L., Mandelkern M. A., Olmstead R. E., Jou J., Tiongson E., Allen V. et al. Neural substrates of resisting craving during cigarette cue exposure. Biol Psychiatry 2007; 62: 642-51.
17. McClernon F. J., Hiott F. B., Huettel S. A., Rose J. E. Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues. Neuropsychopharmacology 2005; 30: 1940-7.
18. Lee J. H., Lim Y., Wiederhold B. K., Graham S. J. A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments. Appl Psychophysiol Biofeedback 2005; 30: 195-204.
19. Wang Z., Faith M., Patterson F., Tang K., Kerrin K., Wileyto E. P. et al. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci 2007; 27: 14035-40.
20. Suñer-Soler R., Grau A., Gras M. E., Font-Mayolas S., Silva Y., Dávalos A. et al. Smoking cessation 1 year poststroke and damage to the insular cortex. Stroke 2012; 43: 131-6.
21. Gaznick N., Tranel D., McNutt A., Bechara A. Basal ganglia plus insula damage yields stronger disruption of smoking addiction than basal ganglia damage alone. Nicotine Tob Res 2014; 16: 445-53.
22. Bienkowski P., Zatorski P., Baranowska A., Ryglewicz D., Sienkiewicz-Jarosz H. Insular lesions and smoking cessation after first-ever ischemic stroke: a 3-month follow-up. Neurosci Lett 2010; 478: 161-4.
23. West R., Ussher M., Evans M., Rashid M. Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales. Psychopharmacology (Berl) 2006; 184: 619-27.
24. Sethi V., Yousry T. A., Muhlert N., Ron M., Golay X., Wheeler-Kingshott C. et al. Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry 2012; 83: 877-82.
25. National Institutes of Health National Institute of Neurological Disorders and Stroke. Stroke Scale. 2003. Available at: http://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf.nd (accessed 6 February 2013).
26. Tong D. C., Yenari M. A., Albers G. W., O'Brien M., Marks M. P., Moseley M. E. et al. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology 1998; 50: 864-70.
27. Harris P. A., Taylor R., Thielke R. et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-81.
28. US Department of Health and Human Services. How Tobacco Smoke Causes Disease. The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
29. Hughes J. R. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res 2007; 9: 315-27.
30. Welsch S. K., Smith S. S., Wetter D. W. et al. Development and validation of the Wisconsin Smoking Withdrawal Scale. Exp Clin Psychopharmacol 1999; 7: 354-61.
31. Hughes J. R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986; 43: 289-94.
32. First M. B. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, DSM-IV. Washington, DC: American Psychiatric Association; 1994, pp. 97-327.
33. Stein M. B., Simmons A. N., Feinstein J. S., Paulus M. P. Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am J Psychiatry 2007; 164: 318-27.
34. Damasio A. R., Grabowski T. J., Bechara A. et al. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci 2000; 3: 1049-56.
35. Mayberg H. S., Liotti M., Brannan S. K. et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156: 675-82.
36. Gemar M. C., Kapur S., Segal Z. V., Brown G. M., Houle S. Effects of self-generated sad mood on regional cerebral activity: a PET study in normal subjects. Depression 1996; 4: 81-8.
37. Del Parigi A., Gautier J. F., Chen K. et al. Neuroimaging and obesity: mapping the brain responses to hunger and satiation in humans using positron emission tomography. Ann NY Acad Sci 2002; 967: 389-97.
38. Chuah Y. M., Venkatraman V., Dinges D. F., Chee M. W. The neural basis of interindividual variability in inhibitory efficiency after sleep deprivation. J Neurosci 2006; 26: 7156-62.
39. Braun A. R., Balkin T. J., Wesenten N. J. et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain 1997; 120: 1173-97.
40. Dang-Vu T. T., Desseilles M., Laureys S. et al. Cerebral correlates of delta waves during non-REM sleep revisited. Neuroimage 2005; 28: 14-21.
41. Clark C. M., Fleming J. A., Li D. et al. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Arch Neurol 1992; 49: 641-3.
42. Hyndman D., Ashburn A. People with stroke living in the community: Attention deficits, balance ADL ability and falls. Disabil Rehabil 2003; 25: 817-22.
43. Menon V., Uddin L. Q. Saliency, switching, attention and control: a network model of insula function. Brain Struct Function 2010; 214: 655-67.
44. Hatsukami D. K., Hughes J. R., Pickens R. W., Svikis D. Tobacco withdrawal symptoms: an experimental analysis. Psychopharmacology (Berl) 1984; 84: 231-6.
45. Lewis A., Miller J. H., Lea R. A. Monoamine oxidase and tobacco dependence. Neurotoxicology 2007; 28: 182-95.
46. Wang H., Sun X. Desensitized nicotinic receptors in brain. Brain Res Brain Res Rev 2005; 48: 420-37.
47. Koob G. F., Bloom F. E. Cellular and molecular mechanisms of drug dependence. Science 1988; 242: 715-23.
48. Naqvi N. H., Bechara A. The hidden island of addiction: the insula. Trends Neurosci 2009; 32: 56-67.
49. Yerger V. B., Wertz M., McGruder C., Froelicher E. S., Malone R. E. Nicotine replacement therapy: perceptions of African-American smokers seeking to quit. J Natl Med Assoc 2008; 100: 230-6.
50. Black A., Beard E., Brown J., Fidler J., West R. Beliefs about the harms of long-term use of nicotine replacement therapy: perceptions of smokers in England. Addiction 2012; 107: 2037-42.
51. Shiffman S. Tobacco 'chippers'-individual differences in tobacco dependence. Psychopharmacology (Berl) 1989; 97: 539-47.